基于血浆代谢状态对动脉粥样硬化进行分层
在荷兰一所大学医院开展的横断面队列研究,纳入302例体重指数≥27 kg/m²的成人,整合血浆代谢组学与临床元数据量化个体「致动脉粥样硬化状态」连续谱。分析证实该谱在不同临床条件下可推广,识别出与致动脉粥样硬化状态相关的代谢物及代谢通路,并在验证队列中显示相关代谢物也与未来心血管疾病相关。
要点
- 基于血浆代谢组学可量化从非致动脉粥样硬化到高度致动脉粥样硬化的连续状态谱。
- 该致动脉粥样硬化状态谱在肥胖代谢健康者与代谢综合征患者中均得到验证。
- γ-谷氨酰-谷氨酸和异香草酸硫酸酯等代谢物与致动脉粥样硬化状态相关。
核心结论
- 血浆代谢组学可提供动脉粥样硬化风险状态的全局视图。
- 与致动脉粥样硬化状态相关的代谢物也与未来心血管疾病相关。
研究设计与样本
- 荷兰一所大学医院的横断面队列研究,共纳入302例体重指数≥27 kg/m²的成人受试者。
- 整合血浆代谢组学与临床元数据,量化每位个体的「致动脉粥样硬化状态」,形成从非致动脉粥样硬化到高度致动脉粥样硬化的连续谱。
主要发现
- 对不同临床状况个体组(如肥胖但代谢健康者与代谢综合征患者)的分析证实了该状态谱的可推广性。
- 分析揭示了每种临床状况内致动脉粥样硬化状态的广泛变异。
- 识别出与致动脉粥样硬化状态相关的代谢物,如γ-谷氨酰-谷氨酸和异香草酸硫酸酯,且不受特定临床状况影响。
- 分析进一步凸显了苯丙氨酸和酪氨酸分解代谢以及雌激素和苯丙素类生物合成等代谢通路。
- 验证队列证实健康受试者(动脉粥样硬化斑块可见之前)存在致动脉粥样硬化状态的变异,且与致动脉粥样硬化状态相关的代谢物也与未来心血管疾病相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Atherosclerosis is a dominant cause of cardiovascular disease (CVD), including myocardial infarction and stroke. OBJECTIVE: To investigate metabolic states that are associated with the development of atherosclerosis. METHODS: Cross-sectional cohort study at a university hospital in the Netherlands. A total of 302 adult subjects with a body mass index (BMI) ≥ 27 kg/m2 were included. We integrated plasma metabolomics with clinical metadata to quantify the "atherogenic state" of each individual, providing a continuous spectrum of atherogenic states that ranges between nonatherogenic states to highly atherogenic states. RESULTS: Analysis of groups of individuals with different clinical conditions-such as metabolically healthy individuals with obesity, and individuals with metabolic syndrome-confirmed the generalizability of this spectrum; revealed a wide variation of atherogenic states within each condition; and allowed identification of metabolites that are associated with the atherogenic state regardless of the particular condition, such as gamma-glutamyl-glutamic acid and homovanillic acid sulfate. The analysis further highlighted metabolic pathways such as catabolism of phenylalanine and tyrosine and biosynthesis of estrogens and phenylpropanoids. Using validation cohorts, we confirmed variation in atherogenic states in healthy subjects (before atherosclerosis plaques become visible), and showed that metabolites associated with the atherogenic state were also associated with future CVD. CONCLUSION: Our results provide a global view of atherosclerosis risk states using plasma metabolomics.
引用
- Menaker Y, van den Munckhof I, Scarpa A, et al. Stratification of Atherosclerosis based on Plasma Metabolic States. J Clin Endocrinol Metab. 2024. PMID: 38044551. doi:10.1210/clinem/dgad672
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。